Course Description |
|
Course Name |
: |
Central Nervous System Pharmacology |
|
Course Code |
: |
FAR542 |
|
Course Type |
: |
Compulsory |
|
Level of Course |
: |
Second Cycle |
|
Year of Study |
: |
1 |
|
Course Semester |
: |
Spring (16 Weeks) |
|
ECTS |
: |
6 |
|
Name of Lecturer(s) |
: |
Prof.Dr. YUSUF KARATAŞ Prof.Dr. FAZİLET AKSU |
|
Learning Outcomes of the Course |
: |
Knows the anatomical and cellular structure of central nervous system. Knows the physiology of central nervous system Learns the functions of the central nervous system. Knows the central nervous system diseases Knows the drugs used in central nervous system diseases
|
|
Mode of Delivery |
: |
Face-to-Face |
|
Prerequisites and Co-Prerequisites |
: |
None |
|
Recommended Optional Programme Components |
: |
None |
|
Aim(s) of Course |
: |
To gain knowledge about the organization and function of central nervous system. To learn about central nervous system diseases and drugs used |
|
Course Contents |
: |
Anatomical and cellular organisation and physiology of the central nervous system. The nerve, synapses and synaptic transmission. Ion channels and neurotransmitters. Pharmacology of drugs used in central nervous system diseases. |
|
Language of Instruction |
: |
Turkish |
|
Work Place |
: |
Classroom. |
|
|
Course Outline /Schedule (Weekly) Planned Learning Activities |
| Week | Subject | Student's Preliminary Work | Learning Activities and Teaching Methods |
|
1 |
Anatomical structure of the central nervous system |
Suggested reading |
Power Point presentation |
|
2 |
Cellular organisation of the central nervous system: The nerve |
Suggested reading |
Power Point presentation |
|
3 |
Transmission between nerves, synapses |
Suggested reading |
Power Point presentation |
|
4 |
Ion channels and neurotransmitters |
Suggested reading |
Power Point presentation |
|
5 |
Amin neurotransmitters |
Suggested reading |
Power Point presentation |
|
6 |
Aminoacid neuromediators |
Suggested reading |
Power Point presentation |
|
7 |
Peptide neuromediators |
Suggested reading |
Power Point presentation |
|
8 |
Mid-term exam |
Exam study |
Oral exam |
|
9 |
Site of action of drugs |
Suggested reading |
Power Point presentation |
|
10 |
General anaesthetics |
Suggested reading |
Power Point presentation |
|
11 |
Local anaesthetics |
Suggested reading |
Power Point presentation |
|
12 |
Antidepressants |
Suggested reading |
Power Point presentation |
|
13 |
Antiepileptics |
Suggested reading |
Power Point presentation |
|
14 |
Analgesics: Opioids |
Suggested reading |
Power Point presentation |
|
15 |
Analgesics: Non-stereodale antiinflammatory drugs |
Suggested reading |
Power Point presentation |
|
16/17 |
Final exam |
Exam study |
Oral exam, participation in lessons and discussion, homework |
|
|
| Contribution of the Course to Key Learning Outcomes |
| # | Key Learning Outcome | Contribution* |
|
1 |
Students gain the ability to research on the areas like preventing irrational drug use detecting the problems due to drug use |
5 |
|
2 |
Students gain basic pharmacological information |
5 |
|
3 |
Students have the ability to take on the responsibilities of pharmacology |
5 |
|
4 |
Students know the experimental research techniques in pharmacology |
3 |
|
5 |
Students gain the ability to present their knowledge in an academic environment |
5 |
|
6 |
Students have an ability to access scientific information |
5 |
|
7 |
Students are informed about pharmacovigilance |
5 |
|
8 |
Students have the ability to apply the basic principles of rational drug use on daily practice |
5 |
|
9 |
Students gain the ability to take place in the in vitro/ in vivo animal experiments |
3 |
|
10 |
Students gain the ability to plan and conduct experimental pharmacological projects and analyze the experimental results. |
3 |
|
11 |
Students gain the ability to follow present literature in the field of pharmacology |
4 |
|
12 |
Students guide the assistant health personnel to receive pharmacology education |
4 |
|
13 |
Students are informed about rational drug use |
5 |
|
14 |
Students know the pharmacological research areas |
4 |
| * Contribution levels are between 0 (not) and 5 (maximum). |
|
|